Product Images Everolimus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Everolimus NDC 51991-380 by Breckenridge Pharmaceutical, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - everolimus 01

Chemical Structure - everolimus 01

Figure 1 - everolimus 02

Figure 1 - everolimus 02

This appears to be a table of some sort, with headings listed as "CGFR (MDRD 4) (ml,/min/1.78m*+2)", "Sc", "D3", "W2", "Wi", "Wb", "W6", "Mz", "M3", "Ma", "Neb", "M5", "M6", "Mo", "NIz", "Mip", and "W24". The numbers listed under each heading vary between 0 and 110. It is likely that this table is related to a medical study or experiment, possibly involving different treatment groups.*

PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Blister Pack Carton - everolimus 03

PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Blister Pack Carton - everolimus 03

This is a medication called Everolimus Tablets, available in 025 mg and 25 mg per tablet dosages, and the package insert provides information on how to store the medication properly, and a warning to keep it away from children. The medication guide is enclosed for dispensing purposes. The manufacturer is Nato Pharma Limited and it is distributed in the USA by Berkn, CT. The NDC numbers for the respective dosages are 51991-37860 and 51991-37960.*

PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Blister Pack - everolimus 04

PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Blister Pack - everolimus 04

This is a description of two different NDC codes (51991-379-99 and 51991-379-09) for Everolimus Tablet at a strength of 0.25 mg. The tablets were distributed by two different companies, Breci Pharma and Brockenridge Pharmaceutical Inc., respectively. The location of Breci Pharma is given as Berlin, CT and the location of Brockenridge Pharmaceutical Inc. is given as either Berlin, CT or Berea, CT with various dates listed. Natco Pharma Ltd. in India is also mentioned as an identifier in the distribution. The text contains some inaccuracies and confusion in the formatting, making it difficult to read.*

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Pack Carton - everolimus 05

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Pack Carton - everolimus 05

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Pack - everolimus 06

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Blister Pack - everolimus 06

PRINCIPAL DISPLAY PANEL - 0.75 mg Tablet Blister Pack Carton - everolimus 07

PRINCIPAL DISPLAY PANEL - 0.75 mg Tablet Blister Pack Carton - everolimus 07

This is a description of a medication called Everolimus Tablets. The dosage details are mentioned and instructions about storage and handling are given. The manufacturer and distributor details are also mentioned, along with information about reporting side effects. The medication is only available with a prescription, and it comes in a carton containing six individual blisters with ten tablets each. The text also mentions the strength of the tablets, which is 0.75 mg per tablet.*

PRINCIPAL DISPLAY PANEL - 0.75 mg Tablet Blister Pack - everolimus 08

PRINCIPAL DISPLAY PANEL - 0.75 mg Tablet Blister Pack - everolimus 08

This is a set of -generated labels for Everolimus tablets. The labels contain the drug's strength (0.75 mg), its National Drug Code (NDC) number (51991-381-99), and the name of the pharmaceutical company that distributed the tablets (Breckenridge Pharmaceutical or Breckenridge Pharmacautical Inc.) along with their address. The labels also show the date the tablets were packaged (in various formats such as "0412021" or "042021 1 5 | 45").*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.